Jason Tsai, M.D., M.S. is currently the Chief Medical Officer & Advisor at HanchorBio Inc., focusing on next generation intelligent biologics. With a background in clinical development, precision medicine, and translational research, Jason also has experience at companies such as AbbVie and Gilead Sciences. Their expertise includes areas such as oncology, cardiovascular therapeutics, and translational medicine, making him a valuable asset in the biotech and pharmaceutical industries.
June 1, 2023 - present
September, 2023